HEALWELL AI Appoints Beatrice York, Dr. Marcel Reichart, and Reeva Misra to Strategic Advisory Board
Toronto, Ontario--(Newsfile Corp. - November 19, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased
2024-11-19 3:15 AM EST
HEALWELL Reports Record Revenue and Increased Customer Activity from Pharmaceutical Partners in Q3-2024
HEALWELL achieved record quarterly revenue from continuing operations of $13.7 million in Q3-2024, 738% higher than the $1.6 million generated in Q3-2023 and 153% higher than the $5.4 million generated in Q2-2024. Quarterly revenues were driven by HEALWELL completing the acquisitions of BioPharma Services Inc. and VeroSource Solutions Inc. during Q3-2024. Management maintains a positive outlook and based on current M&A pipeline continues to expect to make further M&A announcements by year-end...
2024-11-12 5:00 AM EST
HEALWELL's Pentavere Receives Prestigious Prix Galien USA 2024 Award for Best Digital Health Startup for Its Contributions in AI for Life Sciences Industry
The Prix Galien Award is among the global health innovation industry's most renowned honors, recognizing outstanding biomedical, medical, and technology achievements that improve the human condition and is considered the industry's equivalent of the Nobel Prize. Pentavere's DARWEN™ AI platform was awarded for its proven contribution in making healthcare more accessible and personalized for patients and for using various forms of AI including generative AI to help identify patients and detect...
2024-11-12 3:15 AM EST
HEALWELL Provides Corporate Update on Accelerating Commercialization and Expansion of Pharmaceutical Partnerships by Leveraging Its Best-in-Class Patient Identification Capabilities
HEALWELL's AI and data science subsidiaries have executed 5 new Master Services Agreements ("MSA") with new pharmaceutical partners in Q3-2024; bringing the total number of MSAs with life sciences partners to 27, which includes 6 of the top 10 pharmaceutical companies in the world. HEALWELL's AI and data science subsidiaries generated patient identification revenue from 23 of these pharmaceutical partners in Q3-2024. HEALWELL subsidiary, Khure Health, has executed an MSA for patient...
2024-11-05 3:15 AM EST
HEALWELL AI to Announce Third Quarter 2024 Financial Results on November 12, 2024
Toronto, Ontario--(Newsfile Corp. - November 4, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the Company will release its Fiscal Third Quarter 2024 financial results for the period ended September 30, 2024, on Tuesday, November 12, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 1:00...
2024-11-04 4:15 PM EST
WELL Health and HEALWELL AI Expand Strategic Alliance Agreement to Develop an AI-Enhanced Clinical Trials Program to Accelerate Innovation and Improve Patient Outcomes
WELL Health and HEALWELL AI announce the expansion of their multi-year agreement that allows WELL and HEALWELL to launch and manage clinical trial sites at WELL Health clinic locations across Canada. Leveraging HEALWELL's Contract Research Organization (CRO) capabilities alongside WELL Health's network of clinics across Canada, positions the partnership as a formidable player in AI-driven clinical trials, and opens up new revenue streams. This partnership allows HEALWELL AI to offer an...
2024-10-29 3:15 AM EDT
HEALWELL AI Announces Strategic Investment and Commercialization Agreement with Abstractive Health to Advance Generative AI-Powered Clinical Documentation Solutions
HEALWELL AI completes a strategic investment in NY-based Abstractive Health, alongside lead investor Rho Capital Partners, to support the development of AI-driven clinical documentation technology. Concurrent with the investment, HEALWELL also entered into a commercial agreement with Abstractive Health that provides HEALWELL with exclusive distribution rights to the Canadian outpatient healthcare market. Abstractive Health's AI software leverages LLMs and other generative AI technology to...
2024-10-22 5:00 AM EDT
BioPharma Services Announces Expansion into Late-Stage Patient Trials and Integration with HEALWELL's Artificial Intelligence Platform Capabilities to Become a Full-Service Next Generation CRO
HEALWELL's subsidiary, BioPharma Services, is expanding into late-stage patient trials through the integration of Canadian Phase Onward, a dedicated clinical research site built within the framework of HEALWELL's Polyclinic Family and Specialty Medicine Facility. This strategic integration is a significant milestone, enhancing BioPharma's ability to manage clinical trials across all phases of drug development and making the business a full-service Contract Research Organization. The move also...
2024-09-19 3:15 AM EDT
HEALWELL AI's Pentavere Nominated for 2024 Prix Galien Award, a Prestigious Award, for Its Contributions in AI for Life Sciences and Announces Participation at Key Medical Conferences
Pentavere is nominated for a 2024 Prix Galien Award for its contributions in AI and data science benefiting the human condition. The award is offered by the Galien Foundation and considered the most prestigious of all honours in the life sciences and pharmaceutical industry which is regularly awarded to recipients who are believed to have had the greatest impact on human health. This is Pentavere AI's third Prix Galien nomination in 3 years for the Best Digital Health Startup category. To...
2024-09-05 3:15 AM EDT
WELL Health's OceanMD and HEALWELL's Intrahealth Announce Partnership to Expand Access to eReferral Healthcare Solutions
British Columbia and Toronto, Ontario--(Newsfile Corp. - August 22, 2024) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF)
2024-08-22 7:15 AM EDT
HEALWELL AI Reports Record Revenue and a Healthy Balance Sheet in Q2-2024
HEALWELL achieved record quarterly revenue from continuing operations of $5.44 million in Q2-2024, 205% higher than the $1.78 million generated in Q2-2023 and 19% higher than the $4.58 million generated in Q1-2024. HEALWELL also reported net income of $2.54 million as compared to a loss of $9.81 million in Q2 2023. This was primarily due to the successful removal and settling of a significant number of liabilities incurred in past years. Management maintains a positive outlook, with...
2024-08-12 4:50 PM EDT
HEALWELL AI to Announce Fiscal Second Quarter 2024 Financial Results on August 12, 2024
Toronto, Ontario--(Newsfile Corp. - August 7, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), an AI and data science company focused on preventative care, is pleased to announce the Company will release its Fiscal Second Quarter 2024 financial results for the period ended June 30, 2024, on Monday, August 12, 2024. The Company will hold a conference call and simultaneous webcast to discuss its results on the same day at 5:30 pm EST (2:30 pm PST). The call...
2024-08-07 4:15 PM EDT
HEALWELL's Intrahealth Announces Patient Management Contract with the New Zealand Department of Corrections
Toronto, Ontario--(Newsfile Corp. - July 31, 2024) - HEALWELL AI Inc. (TSX: AIDX, OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce its subsidiary, Intrahealth, a leading technology solutions provider specializing in electronic health records, has partnered with the New Zealand Department of Corrections to improve offender healthcare through the delivery of a new patient management system. Do
2024-07-31 3:15 AM EDT
Province of New Brunswick Launches New Patient Summary with HEALWELL AI's VeroSource Solutions
VeroSource, a subsidiary of HEALWELL, built the new Patient Summary feature that launched on the MyHealthNB mobile app in partnership with Canada Health Infoway and the Government of New Brunswick. The Patient Summary feature allows users to create a summary of their medical information including medications, immunizations, lab results and imaging reports, which can then be securely shared with healthcare professionals and care providers. By enabling the secure sharing of personal health...
2024-07-25 3:15 AM EDT
HEALWELL AI Provides Corporate Update on Capital Allocation Program and Value Creation Strategy
HEALWELL's current goal is to achieve run rate revenues approaching $100 million by the end of the year from today's current run rate of over $65 million. This goal is underpinned by a robust M&A pipeline where there are several advanced subjects including one signed LOI and helps the Company position itself to achieve profitability on an Adjusted EBITDA basis in 2025. HEALWELL's four acquisitions to date have positioned the company to unlock the power of health data with artificial...
2024-07-23 3:15 AM EDT
WELL Health Launches its AI-powered Co-pilot for Cardiologists powered by HEALWELL AI to Help Improve Detection of Cardiovascular Disease
WELL has launched its new AI-powered physician co-pilot to assist cardiologists in better identifying patients at high risk of cardiovascular disease ("CVD"). WELL is exclusively partnering with HEALWELL AI, a leader in AI enabled disease diagnosis, as an extension of the WELL AI Decision Support ("WAIDS") product offering. The co-pilot will be deployed into WELL Diagnostic Centres, Canada's largest cardiology and medical diagnostic group, providing support and assisting cardiologists in over...
2024-07-17 3:15 AM EDT
HEALWELL Provides Corporate Update Reflecting Strengthened Balance Sheet with $15.5 Million Reduction of Total Liabilities
HEALWELL is pleased to provide an update on its improved balance sheet with the reduction of approximately $15.5 million of liabilities in Q2-2024. HEALWELL has successfully settled certain payment obligations related to the legacy MCI Medical Clinics Inc. ("MCI Ontario") business, resulting in extinguishing $3.9 million in future liabilities including rent and operating costs, and $2.5 million of payments in arrears. In addition, HEALWELL has received forgiveness as expected for the loans...
2024-07-10 7:00 AM EDT
HEALWELL AI Announces Successful Closing of Two Strategic Acquisitions: VeroSource Solutions and BioPharma Services
HEALWELL has completed the previously announced acquisitions of both VeroSource Solutions Inc. and BioPharma Services Inc., which boosts HEALWELL's proforma annualized revenue run-rate to be greater than $65 million and significantly improves HEALWELL's profitability. Serving five different provincial health clients across Canada, VeroSource is an end-to-end, customizable, cloud-based data interoperability platform that enables patients, care providers and administrators to seamlessly access...
2024-07-02 3:15 AM EDT
HEALWELL AI Announces Strategic Investment in xAI to Accelerate Development of Healthcare Focused Large Language Models That Benefit from xAI Developer Ecosystem
HEALWELL completes USD $2,000,000 strategic investment into an xAI investment vehicle as part of its capital allocation strategy where it seeks to enhance and accelerate the development of its healthcare focused data science capabilities by partnering with world class platforms and seeking opportunities to integrate them with its own proprietary data and technology. HEALWELL has made this investment through Think 1st Principles ("T1P"), an investment fund founded by HEALWELL shareholder and...
2024-06-26 3:15 AM EDT
HEALWELL AI Announces Voting Results of 2024 Annual General Meeting of its Shareholders
Toronto, Ontario--(Newsfile Corp. - June 25, 2024) - HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) ("HEALWELL" or the "Company"), a healthcare technology company focused on AI and data science for preventative care, is pleased to announce the voting results from its annual general meeting of the shareholders of the Company held on June 25, 2024 (the "Meeting"). Shareholders holding shares entitled to exercise approximately 77.61% of the votes attributable to all of HEALWELL's outstanding shares...
2024-06-25 4:45 PM EDT